Index by author

01 February 2008; volume 31, issue 2

A

  1. Abe, S.

    1. Morimoto, T. et al "Epidemiology of sarcoidosis in Japan." European Respiratory Journal 31.2 (2008): 372-379. Web. 20 Jan. 2020.

  2. Aizawa, H.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  3. Aldington, S.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  4. Antus, B.

    1. Kullmann, T. et al "Environmental temperature and relative humidity influence exhaled breath condensate pH." European Respiratory Journal 31.2 (2008): 474-475. Web. 20 Jan. 2020.

  5. Asenjo, M. A.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  6. Aznar, J.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  7. Azuma, A.

    1. Morimoto, T. et al "Epidemiology of sarcoidosis in Japan." European Respiratory Journal 31.2 (2008): 372-379. Web. 20 Jan. 2020.

B

  1. Balzano, G.

    1. Fuschillo, S., A. De Felice, and G. Balzano. "Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms." European Respiratory Journal 31.2 (2008): 396-406. Web. 20 Jan. 2020.

  2. Barnes, P. J.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  3. Barta, I.

    1. Kullmann, T. et al "Environmental temperature and relative humidity influence exhaled breath condensate pH." European Respiratory Journal 31.2 (2008): 474-475. Web. 20 Jan. 2020.

  4. Beasley, R.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  5. Beckert, L.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  6. Bont, J.

    1. Verheij, T. et al " From the authors ." European Respiratory Journal 31.2 (2008): 478. Web. 20 Jan. 2020.

  7. Bos, A. P.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

  8. Boulet, L. P.

    1. Chapman, K. R. et al "Suboptimal asthma control: prevalence, detection and consequences in general practice." European Respiratory Journal 31.2 (2008): 320-325. Web. 20 Jan. 2020.

  9. Bozó, J.

    1. Faludi, R. et al "Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension." European Respiratory Journal 31.2 (2008): 475-476. Web. 20 Jan. 2020.

  10. Brambilla, C.

    1. Brambilla, C., and M. Colonna. "Cannabis: the next villain on the lung cancer battlefield?." European Respiratory Journal 31.2 (2008): 227-228. Web. 20 Jan. 2020.

  11. Broekaert, L.

    1. Vandevoorde, J. et al "Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity." European Respiratory Journal 31.2 (2008): 391-395. Web. 20 Jan. 2020.

  12. Brown, R. A.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  13. Brusasco, V.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  14. Buesching, G.

    1. Puhan, M. A. et al "COPD patients' ability to follow exercise influences short-term outcomes of rehabilitation." European Respiratory Journal 31.2 (2008): 304-310. Web. 20 Jan. 2020.

  15. Burge, P. S.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  16. Bush, A.

    1. Wilson, N. M., and A. Bush. "β2-Adrenoceptor polymorphisms and asthma phenotypes: interactions with passive smoking." European Respiratory Journal 31.2 (2008): 479-480. Web. 20 Jan. 2020.

C

  1. Calverley, P. M. A.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  2. Cazzola, M.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  3. Celli, B. R.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  4. Chapman, K. R.

    1. Chapman, K. R. et al "Suboptimal asthma control: prevalence, detection and consequences in general practice." European Respiratory Journal 31.2 (2008): 320-325. Web. 20 Jan. 2020.

  5. Charles, P. G. P.

    1. Charles, P. G. P.. "Oral antibiotics prior to hospitalisation for community-acquired pneumonia." European Respiratory Journal 31.2 (2008): 478-479. Web. 20 Jan. 2020.

  6. Chauliac, E. S.

    1. Kuehni, C. E. et al "Snoring in preschool children: prevalence, severity and risk factors." European Respiratory Journal 31.2 (2008): 326-333. Web. 20 Jan. 2020.

  7. Clarke, G. W.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  8. Colonna, M.

    1. Brambilla, C., and M. Colonna. "Cannabis: the next villain on the lung cancer battlefield?." European Respiratory Journal 31.2 (2008): 227-228. Web. 20 Jan. 2020.

  9. Coote, J. E.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  10. Cordier, J-F.

    1. Schuller, A. et al "Finger clubbing and altered carbon monoxide transfer capacity in cannabis smokers." European Respiratory Journal 31.2 (2008): 473-474. Web. 20 Jan. 2020.

  11. Cottin, V.

    1. Schuller, A. et al "Finger clubbing and altered carbon monoxide transfer capacity in cannabis smokers." European Respiratory Journal 31.2 (2008): 473-474. Web. 20 Jan. 2020.

  12. Cox, B.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  13. Czirják, L.

    1. Faludi, R. et al "Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension." European Respiratory Journal 31.2 (2008): 475-476. Web. 20 Jan. 2020.

D

  1. Dahl, R.

    1. Hoffmann, H. J. et al "Human skin keratins are the major proteins in exhaled breath condensate." European Respiratory Journal 31.2 (2008): 380-384. Web. 20 Jan. 2020.

  2. Dalhoff, K.

    1. Schaaf, B., and K. Dalhoff. " From the authors ." European Respiratory Journal 31.2 (2008): 479. Web. 20 Jan. 2020.

  3. De Felice, A.

    1. Fuschillo, S., A. De Felice, and G. Balzano. "Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms." European Respiratory Journal 31.2 (2008): 396-406. Web. 20 Jan. 2020.

  4. Denyer, J. C.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  5. Devroey, D.

    1. Vandevoorde, J. et al "Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity." European Respiratory Journal 31.2 (2008): 391-395. Web. 20 Jan. 2020.

  6. Dinh-Xuan, A. T.

    1. Hoeper, M. M., and A. T. Dinh-Xuan. "Pulmonary hypertension: basic concepts and practical management." European Respiratory Journal 31.2 (2008): 236-237. Web. 20 Jan. 2020.

  7. Donaldson, K.

    1. Mroz, R. M. et al "Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways." European Respiratory Journal 31.2 (2008): 241-251. Web. 20 Jan. 2020.

  8. Drost, E. M.

    1. Mroz, R. M. et al "Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways." European Respiratory Journal 31.2 (2008): 241-251. Web. 20 Jan. 2020.

  9. Dupuis, J.

    1. Dupuis, J., and M. M. Hoeper. "Endothelin receptor antagonists in pulmonary arterial hypertension." European Respiratory Journal 31.2 (2008): 407-415. Web. 20 Jan. 2020.

E

  1. Enghild, J. J.

    1. Hoffmann, H. J. et al "Human skin keratins are the major proteins in exhaled breath condensate." European Respiratory Journal 31.2 (2008): 380-384. Web. 20 Jan. 2020.

  2. Ernst, M.

    1. Jafari, C. et al "Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot." European Respiratory Journal 31.2 (2008): 261-265. Web. 20 Jan. 2020.

  3. Ewig, S.

    1. Krüger, S. et al "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes." European Respiratory Journal 31.2 (2008): 349-355. Web. 20 Jan. 2020.

F

  1. Faludi, R.

    1. Faludi, R. et al "Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension." European Respiratory Journal 31.2 (2008): 475-476. Web. 20 Jan. 2020.

  2. Ferrer, M.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  3. Florquin, S.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

  4. Franciosi, L. G.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  5. Franssen, E.

    1. Chapman, K. R. et al "Suboptimal asthma control: prevalence, detection and consequences in general practice." European Respiratory Journal 31.2 (2008): 320-325. Web. 20 Jan. 2020.

  6. Frey, M.

    1. Puhan, M. A. et al "COPD patients' ability to follow exercise influences short-term outcomes of rehabilitation." European Respiratory Journal 31.2 (2008): 304-310. Web. 20 Jan. 2020.

  7. Fuschillo, S.

    1. Fuschillo, S., A. De Felice, and G. Balzano. "Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms." European Respiratory Journal 31.2 (2008): 396-406. Web. 20 Jan. 2020.

G

  1. Garcia, M. A.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  2. Greenberg-Dotan, S.

    1. Reuveni, H. et al "Elevated healthcare utilisation in young adult males with obstructive sleep apnoea." European Respiratory Journal 31.2 (2008): 273-279. Web. 20 Jan. 2020.

  3. Greinert, U.

    1. Jafari, C. et al "Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot." European Respiratory Journal 31.2 (2008): 261-265. Web. 20 Jan. 2020.

H

  1. Haegens, A.

    1. Haegens, A. et al "Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents." European Respiratory Journal 31.2 (2008): 252-260. Web. 20 Jan. 2020.

  2. Haitsma, J. J.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

  3. Hak, E.

    1. Verheij, T. et al " From the authors ." European Respiratory Journal 31.2 (2008): 478. Web. 20 Jan. 2020.

  4. Hanacek, J.

    1. Tatar, M., J. Hanacek, and J. Widdicombe. "The expiration reflex from the trachea and bronchi." European Respiratory Journal 31.2 (2008): 385-390. Web. 20 Jan. 2020.

  5. Hanaoka, Y.

    1. Teramoto, S. et al "Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65." European Respiratory Journal 31.2 (2008): 477-478. Web. 20 Jan. 2020.

  6. Hansell, A.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  7. Harwood, M.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  8. Heeringa, P.

    1. Haegens, A. et al "Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents." European Respiratory Journal 31.2 (2008): 252-260. Web. 20 Jan. 2020.

  9. Heijerman, H.

    1. Heijerman, H.. "Cystic Fibrosis. Third Edition." European Respiratory Journal 31.2 (2008): 482. Web. 20 Jan. 2020.

  10. Hervé, P.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  11. Hibi, S.

    1. Teramoto, S. et al "Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65." European Respiratory Journal 31.2 (2008): 477-478. Web. 20 Jan. 2020.

  12. Ho, P. L.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

  13. Hoeper, M. M.

    1. Hoeper, M. M., and A. T. Dinh-Xuan. "Pulmonary hypertension: basic concepts and practical management." European Respiratory Journal 31.2 (2008): 236-237. Web. 20 Jan. 2020.
    2. Dupuis, J., and M. M. Hoeper. "Endothelin receptor antagonists in pulmonary arterial hypertension." European Respiratory Journal 31.2 (2008): 407-415. Web. 20 Jan. 2020.

  14. Hoes, A.

    1. Verheij, T. et al " From the authors ." European Respiratory Journal 31.2 (2008): 478. Web. 20 Jan. 2020.

  15. Hoffmann, H. J.

    1. Hoffmann, H. J. et al "Human skin keratins are the major proteins in exhaled breath condensate." European Respiratory Journal 31.2 (2008): 380-384. Web. 20 Jan. 2020.

  16. Holownia, A.

    1. Mroz, R. M. et al "Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways." European Respiratory Journal 31.2 (2008): 241-251. Web. 20 Jan. 2020.

  17. Hong, Z.

    1. Weir, E. K., M. Obreztchikova, and Z. Hong. "Fenfluramine: riddle or Rosetta stone?." European Respiratory Journal 31.2 (2008): 232-235. Web. 20 Jan. 2020.

  18. Horváth, I.

    1. Kullmann, T. et al "Environmental temperature and relative humidity influence exhaled breath condensate pH." European Respiratory Journal 31.2 (2008): 474-475. Web. 20 Jan. 2020.

  19. Hoshino, T.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  20. Hot, A.

    1. Schuller, A. et al "Finger clubbing and altered carbon monoxide transfer capacity in cannabis smokers." European Respiratory Journal 31.2 (2008): 473-474. Web. 20 Jan. 2020.

  21. Humbert, M.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  22. Hurle, M. J.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

I

  1. Imaoka, H.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  2. Ishii, M.

    1. Teramoto, S. et al "Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65." European Respiratory Journal 31.2 (2008): 477-478. Web. 20 Jan. 2020.

  3. Iwasaki, H.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

J

  1. Jacobsen, G.

    1. Jacobsen, G. et al "Longitudinal lung function decline and wood dust exposure in the furniture industry." European Respiratory Journal 31.2 (2008): 334-342. Web. 20 Jan. 2020.

  2. Jafari, C.

    1. Jafari, C. et al "Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot." European Respiratory Journal 31.2 (2008): 261-265. Web. 20 Jan. 2020.

  3. Jaïs, X.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  4. Jimenez, L. A.

    1. Mroz, R. M. et al "Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways." European Respiratory Journal 31.2 (2008): 241-251. Web. 20 Jan. 2020.

  5. Jones, P. W.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

K

  1. Kalsdorf, B.

    1. Jafari, C. et al "Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot." European Respiratory Journal 31.2 (2008): 261-265. Web. 20 Jan. 2020.

  2. Kartounian, J.

    1. Vandevoorde, J. et al "Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity." European Respiratory Journal 31.2 (2008): 391-395. Web. 20 Jan. 2020.

  3. Kato, S.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  4. Kawayama, T.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  5. Kinoshita, T.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  6. Kirsten, D.

    1. Jafari, C. et al "Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot." European Respiratory Journal 31.2 (2008): 261-265. Web. 20 Jan. 2020.

  7. Komócsi, A.

    1. Faludi, R. et al "Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension." European Respiratory Journal 31.2 (2008): 475-476. Web. 20 Jan. 2020.

  8. Kotz, D.

    1. Kotz, D. et al "External validation of a COPD diagnostic questionnaire." European Respiratory Journal 31.2 (2008): 298-303. Web. 20 Jan. 2020.

  9. Krüger, S.

    1. Krüger, S. et al "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes." European Respiratory Journal 31.2 (2008): 349-355. Web. 20 Jan. 2020.

  10. Kudoh, S.

    1. Morimoto, T. et al "Epidemiology of sarcoidosis in Japan." European Respiratory Journal 31.2 (2008): 372-379. Web. 20 Jan. 2020.

  11. Kuehni, C. E.

    1. Kuehni, C. E. et al "Snoring in preschool children: prevalence, severity and risk factors." European Respiratory Journal 31.2 (2008): 326-333. Web. 20 Jan. 2020.

  12. Kullmann, T.

    1. Kullmann, T. et al "Environmental temperature and relative humidity influence exhaled breath condensate pH." European Respiratory Journal 31.2 (2008): 474-475. Web. 20 Jan. 2020.

  13. Kumánovics, G.

    1. Faludi, R. et al "Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension." European Respiratory Journal 31.2 (2008): 475-476. Web. 20 Jan. 2020.

  14. Kume, H.

    1. Teramoto, S. et al "Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65." European Respiratory Journal 31.2 (2008): 477-478. Web. 20 Jan. 2020.

L

  1. Lachmann, B.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

  2. Lange, C.

    1. Jafari, C. et al "Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot." European Respiratory Journal 31.2 (2008): 261-265. Web. 20 Jan. 2020.

  3. Law, W. S.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

  4. Ledbetter, C. L.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  5. Le Pavec, J.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  6. Le Souëf, P. N.

    1. Zhang, G., and P. N. Le Souëf. " From the authors ." European Respiratory Journal 31.2 (2008): 480-481. Web. 20 Jan. 2020.

  7. Leung, C. C.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

  8. Leung, M.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

  9. Levy, M. L.

    1. Levy, M. L.. "Guideline-defined asthma control: a challenge for primary care." European Respiratory Journal 31.2 (2008): 229-231. Web. 20 Jan. 2020.

  10. Li, H.

    1. Mroz, R. M. et al "Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways." European Respiratory Journal 31.2 (2008): 241-251. Web. 20 Jan. 2020.

  11. Lichtin, A. E.

    1. Mehta, A. et al "Platelet larceny: spurious hypoxaemia due to extreme thrombocytosis." European Respiratory Journal 31.2 (2008): 469-472. Web. 20 Jan. 2020.

  12. Lutter, R.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

M

  1. MacNee, W.

    1. Mroz, R. M. et al "Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways." European Respiratory Journal 31.2 (2008): 241-251. Web. 20 Jan. 2020.
    2. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  2. Mahler, D. A.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  3. Make, B.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  4. Marre, R.

    1. Krüger, S. et al "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes." European Respiratory Journal 31.2 (2008): 349-355. Web. 20 Jan. 2020.

  5. Martinez, F. J.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  6. Mehta, A.

    1. Mehta, A. et al "Platelet larceny: spurious hypoxaemia due to extreme thrombocytosis." European Respiratory Journal 31.2 (2008): 469-472. Web. 20 Jan. 2020.

  7. Menéndez, R.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  8. Merkus, M. P.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

  9. Miravitlles, M.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  10. Morimoto, T.

    1. Morimoto, T. et al "Epidemiology of sarcoidosis in Japan." European Respiratory Journal 31.2 (2008): 372-379. Web. 20 Jan. 2020.

  11. Mossman, B. T.

    1. Haegens, A. et al "Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents." European Respiratory Journal 31.2 (2008): 252-260. Web. 20 Jan. 2020.

  12. Mroz, R. M.

    1. Mroz, R. M. et al "Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways." European Respiratory Journal 31.2 (2008): 241-251. Web. 20 Jan. 2020.

  13. Murdoch, R. D.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

N

  1. Nelemans, P.

    1. Kotz, D. et al "External validation of a COPD diagnostic questionnaire." European Respiratory Journal 31.2 (2008): 298-303. Web. 20 Jan. 2020.

  2. Nukiwa, T.

    1. Morimoto, T. et al "Epidemiology of sarcoidosis in Japan." European Respiratory Journal 31.2 (2008): 372-379. Web. 20 Jan. 2020.

O

  1. O’Connor, B. J.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  2. Obreztchikova, M.

    1. Weir, E. K., M. Obreztchikova, and Z. Hong. "Fenfluramine: riddle or Rosetta stone?." European Respiratory Journal 31.2 (2008): 232-235. Web. 20 Jan. 2020.

  3. Okamoto, M.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  4. Oksenberg, A.

    1. Reuveni, H. et al "Elevated healthcare utilisation in young adult males with obstructive sleep apnoea." European Respiratory Journal 31.2 (2008): 273-279. Web. 20 Jan. 2020.

  5. Oritsu, M.

    1. Morimoto, T. et al "Epidemiology of sarcoidosis in Japan." European Respiratory Journal 31.2 (2008): 372-379. Web. 20 Jan. 2020.

  6. Ouchi, Y.

    1. Teramoto, S. et al "Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65." European Respiratory Journal 31.2 (2008): 477-478. Web. 20 Jan. 2020.

P

  1. Page, C. P.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.
    2. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  2. Palange, P.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  3. Papassotiriou, J.

    1. Krüger, S. et al "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes." European Respiratory Journal 31.2 (2008): 349-355. Web. 20 Jan. 2020.

  4. Papp, L.

    1. Faludi, R. et al "Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension." European Respiratory Journal 31.2 (2008): 475-476. Web. 20 Jan. 2020.

  5. Parambil, J. G.

    1. Mehta, A. et al "Platelet larceny: spurious hypoxaemia due to extreme thrombocytosis." European Respiratory Journal 31.2 (2008): 469-472. Web. 20 Jan. 2020.

  6. Parent, F.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  7. Parr, D.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  8. Pistolesi, M.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  9. Pritchard, A.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  10. Puhan, M. A.

    1. Puhan, M. A. et al "COPD patients' ability to follow exercise influences short-term outcomes of rehabilitation." European Respiratory Journal 31.2 (2008): 304-310. Web. 20 Jan. 2020.

R

  1. Rabe, K. F.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  2. Ramirez, P.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  3. Rea, R. M.

    1. Chapman, K. R. et al "Suboptimal asthma control: prevalence, detection and consequences in general practice." European Respiratory Journal 31.2 (2008): 320-325. Web. 20 Jan. 2020.

  4. Rennard, S. I.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  5. Reuveni, H.

    1. Reuveni, H. et al "Elevated healthcare utilisation in young adult males with obstructive sleep apnoea." European Respiratory Journal 31.2 (2008): 273-279. Web. 20 Jan. 2020.

  6. Richter, K.

    1. Krüger, S. et al "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes." European Respiratory Journal 31.2 (2008): 349-355. Web. 20 Jan. 2020.

  7. Robinson, G.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  8. Rutten-van Mölken, M. P.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

S

  1. Sahuquillo, J. M.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  2. Savage, T. J.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  3. Schaaf, B.

    1. Schaaf, B., and K. Dalhoff. " From the authors ." European Respiratory Journal 31.2 (2008): 479. Web. 20 Jan. 2020.

  4. Schaumburg, I.

    1. Jacobsen, G. et al "Longitudinal lung function decline and wood dust exposure in the furniture industry." European Respiratory Journal 31.2 (2008): 334-342. Web. 20 Jan. 2020.

  5. Schins, R. P. F.

    1. Mroz, R. M. et al "Nanoparticle-driven DNA damage mimics irradiation-related carcinogenesis pathways." European Respiratory Journal 31.2 (2008): 241-251. Web. 20 Jan. 2020.

  6. Schlünssen, V.

    1. Jacobsen, G. et al "Longitudinal lung function decline and wood dust exposure in the furniture industry." European Respiratory Journal 31.2 (2008): 334-342. Web. 20 Jan. 2020.

  7. Schuermans, D.

    1. Vandevoorde, J. et al "Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity." European Respiratory Journal 31.2 (2008): 391-395. Web. 20 Jan. 2020.

  8. Schuller, A.

    1. Schuller, A. et al "Finger clubbing and altered carbon monoxide transfer capacity in cannabis smokers." European Respiratory Journal 31.2 (2008): 473-474. Web. 20 Jan. 2020.

  9. Schünemann, H. J.

    1. Schünemann, H. J.. "COPD dashboard: about official Documents, Authors, Science, Health status and BOARDs." European Respiratory Journal 31.2 (2008): 238-240. Web. 20 Jan. 2020.
    2. Puhan, M. A. et al "COPD patients' ability to follow exercise influences short-term outcomes of rehabilitation." European Respiratory Journal 31.2 (2008): 304-310. Web. 20 Jan. 2020.

  10. Sigsgaard, T.

    1. Jacobsen, G. et al "Longitudinal lung function decline and wood dust exposure in the furniture industry." European Respiratory Journal 31.2 (2008): 334-342. Web. 20 Jan. 2020.

  11. Silverman, M.

    1. Kuehni, C. E. et al "Snoring in preschool children: prevalence, severity and risk factors." European Respiratory Journal 31.2 (2008): 326-333. Web. 20 Jan. 2020.

  12. Simcock, D. E.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  13. Simon-Tuval, T.

    1. Reuveni, H. et al "Elevated healthcare utilisation in young adult males with obstructive sleep apnoea." European Respiratory Journal 31.2 (2008): 273-279. Web. 20 Jan. 2020.

  14. Simonneau, G.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  15. Simor, T.

    1. Faludi, R. et al "Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension." European Respiratory Journal 31.2 (2008): 475-476. Web. 20 Jan. 2020.

  16. Sitbon, O.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  17. Soubrier, F.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  18. Souza, R.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  19. Spaar, A.

    1. Puhan, M. A. et al "COPD patients' ability to follow exercise influences short-term outcomes of rehabilitation." European Respiratory Journal 31.2 (2008): 304-310. Web. 20 Jan. 2020.

  20. Spina, D.

    1. Brown, R. A. et al "Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects." European Respiratory Journal 31.2 (2008): 311-319. Web. 20 Jan. 2020.

  21. Stockley, R.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  22. Strassburg, A.

    1. Jafari, C. et al "Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot." European Respiratory Journal 31.2 (2008): 261-265. Web. 20 Jan. 2020.

  23. Strippoli, M-P. F.

    1. Kuehni, C. E. et al "Snoring in preschool children: prevalence, severity and risk factors." European Respiratory Journal 31.2 (2008): 326-333. Web. 20 Jan. 2020.

  24. Sugisaki, K.

    1. Morimoto, T. et al "Epidemiology of sarcoidosis in Japan." European Respiratory Journal 31.2 (2008): 372-379. Web. 20 Jan. 2020.

  25. Sullivan, S. D.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  26. Suttorp, N.

    1. Krüger, S. et al "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes." European Respiratory Journal 31.2 (2008): 349-355. Web. 20 Jan. 2020.

  27. Sztrymf, B.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

T

  1. Tabaksblat, L. M.

    1. Hoffmann, H. J. et al "Human skin keratins are the major proteins in exhaled breath condensate." European Respiratory Journal 31.2 (2008): 380-384. Web. 20 Jan. 2020.

  2. Takei, S.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  3. Tam, C. M.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

  4. Tarasiuk, A.

    1. Reuveni, H. et al "Elevated healthcare utilisation in young adult males with obstructive sleep apnoea." European Respiratory Journal 31.2 (2008): 273-279. Web. 20 Jan. 2020.

  5. Tatar, M.

    1. Tatar, M., J. Hanacek, and J. Widdicombe. "The expiration reflex from the trachea and bronchi." European Respiratory Journal 31.2 (2008): 385-390. Web. 20 Jan. 2020.

  6. Taudorf, E.

    1. Jacobsen, G. et al "Longitudinal lung function decline and wood dust exposure in the furniture industry." European Respiratory Journal 31.2 (2008): 334-342. Web. 20 Jan. 2020.

  7. Teramoto, S.

    1. Teramoto, S. et al "Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65." European Respiratory Journal 31.2 (2008): 477-478. Web. 20 Jan. 2020.

  8. Torres, A.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  9. Tsui, D.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

U

  1. Usuki, J.

    1. Morimoto, T. et al "Epidemiology of sarcoidosis in Japan." European Respiratory Journal 31.2 (2008): 372-379. Web. 20 Jan. 2020.

V

  1. Valencia, M.

    1. Ramirez, P. et al "Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia." European Respiratory Journal 31.2 (2008): 356-362. Web. 20 Jan. 2020.

  2. Valyon, M.

    1. Kullmann, T. et al "Environmental temperature and relative humidity influence exhaled breath condensate pH." European Respiratory Journal 31.2 (2008): 474-475. Web. 20 Jan. 2020.

  3. van der Loos, C. M.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

  4. Vandevoorde, J.

    1. Vandevoorde, J. et al "Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity." European Respiratory Journal 31.2 (2008): 391-395. Web. 20 Jan. 2020.

  5. vanOort, E.

    1. Puhan, M. A. et al "COPD patients' ability to follow exercise influences short-term outcomes of rehabilitation." European Respiratory Journal 31.2 (2008): 304-310. Web. 20 Jan. 2020.

  6. van Schayck, C. P.

    1. Kotz, D. et al "External validation of a COPD diagnostic questionnaire." European Respiratory Journal 31.2 (2008): 298-303. Web. 20 Jan. 2020.

  7. van Woensel, J. B.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

  8. Verbanck, S.

    1. Vandevoorde, J. et al "Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity." European Respiratory Journal 31.2 (2008): 391-395. Web. 20 Jan. 2020.

  9. Verheij, T.

    1. Verheij, T. et al " From the authors ." European Respiratory Journal 31.2 (2008): 478. Web. 20 Jan. 2020.

  10. Vernooy, J. H. J.

    1. Haegens, A. et al "Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents." European Respiratory Journal 31.2 (2008): 252-260. Web. 20 Jan. 2020.

  11. Vigg, A.

    1. Mehta, A. et al "Platelet larceny: spurious hypoxaemia due to extreme thrombocytosis." European Respiratory Journal 31.2 (2008): 469-472. Web. 20 Jan. 2020.

  12. Vincken, W.

    1. Vandevoorde, J. et al "Forced vital capacity and forced expiratory volume in six seconds as predictors of reduced total lung capacity." European Respiratory Journal 31.2 (2008): 391-395. Web. 20 Jan. 2020.

  13. von Baum, H.

    1. Krüger, S. et al "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes." European Respiratory Journal 31.2 (2008): 349-355. Web. 20 Jan. 2020.

W

  1. Watanabe, K.

    1. Imaoka, H. et al "Interleukin-18 production and pulmonary function in COPD." European Respiratory Journal 31.2 (2008): 287-297. Web. 20 Jan. 2020.

  2. Weatherall, M.

    1. Aldington, S. et al "Cannabis use and risk of lung cancer: a case–control study." European Respiratory Journal 31.2 (2008): 280-286. Web. 20 Jan. 2020.

  3. Wedzicha, J. A.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  4. Weir, E. K.

    1. Weir, E. K., M. Obreztchikova, and Z. Hong. "Fenfluramine: riddle or Rosetta stone?." European Respiratory Journal 31.2 (2008): 232-235. Web. 20 Jan. 2020.

  5. Welte, T.

    1. Krüger, S. et al "Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes." European Respiratory Journal 31.2 (2008): 349-355. Web. 20 Jan. 2020.

  6. Wesseling, G. J.

    1. Kotz, D. et al "External validation of a COPD diagnostic questionnaire." European Respiratory Journal 31.2 (2008): 298-303. Web. 20 Jan. 2020.

  7. Widdicombe, J.

    1. Tatar, M., J. Hanacek, and J. Widdicombe. "The expiration reflex from the trachea and bronchi." European Respiratory Journal 31.2 (2008): 385-390. Web. 20 Jan. 2020.

  8. Wilson, N. M.

    1. Wilson, N. M., and A. Bush. "β2-Adrenoceptor polymorphisms and asthma phenotypes: interactions with passive smoking." European Respiratory Journal 31.2 (2008): 479-480. Web. 20 Jan. 2020.

  9. Wong, M. Y.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

  10. Wösten-van Asperen, R. M.

    1. Wösten-van Asperen, R. M. et al "ACE mediates ventilator-induced lung injury in rats via angiotensin II but not bradykinin." European Respiratory Journal 31.2 (2008): 363-371. Web. 20 Jan. 2020.

  11. Wouters, E. F.

    1. Cazzola, M. et al "Outcomes for COPD pharmacological trials: from lung function to biomarkers." European Respiratory Journal 31.2 (2008): 416-469. Web. 20 Jan. 2020.

  12. Wouters, E. F. M.

    1. Haegens, A. et al "Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents." European Respiratory Journal 31.2 (2008): 252-260. Web. 20 Jan. 2020.

Y

  1. Yaïci, A.

    1. Souza, R. et al "Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases." European Respiratory Journal 31.2 (2008): 343-348. Web. 20 Jan. 2020.

  2. Yam, W. C.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

  3. Yamaguchi, Y.

    1. Teramoto, S. et al "Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65." European Respiratory Journal 31.2 (2008): 477-478. Web. 20 Jan. 2020.

  4. Yamamoto, H.

    1. Teramoto, S. et al "Lower respiratory tract infection outcomes are predicted better by an age >80 years than by CURB-65." European Respiratory Journal 31.2 (2008): 477-478. Web. 20 Jan. 2020.

  5. Yew, W. W.

    1. Leung, C. C. et al "Comparison of T-Spot.TB and tuberculin skin test among silicotic patients." European Respiratory Journal 31.2 (2008): 266-272. Web. 20 Jan. 2020.

Z

  1. Zhang, G.

    1. Zhang, G., and P. N. Le Souëf. " From the authors ." European Respiratory Journal 31.2 (2008): 480-481. Web. 20 Jan. 2020.
Back to top
European Respiratory Journal: 31 (2)

Search Within This Issue

Jump to

Manage Table of content Alerts